Inspire Veterinary Partners, Inc.

IVPR Consumer Cyclical Personal Services

Inspire Veterinary Partners, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $16.6 million, roughly unchanged from fiscal 2023. In the quarter to September 2025, revenue grew 6.60%, EPS grew 51.7% and free cash flow grew 79.1%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$3.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
−2.68
Beneish M
−4.20
Dividend safety
n/a
Sep '25 Jun '25 Mar '25 Dec '24 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.38 0.67 0.62 1.60
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(4.65) (11.35) (6.91) (39.24)
P/B ratio
1.43 22.84 3.16 17.02
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
0.73 1.21 1.04 2.08
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(2.67) (2.00) (1.95) (3.45)
EV/FCF
(1.96) (1.72) (1.65) (2.96)
Quick Ratio
0.30 0.03 0.23 0.07
Current Ratio
0.39 0.13 0.39 0.25
Net Debt/EBITDA
(4.50) (4.11) (4.72) (7.81)
Debt/Assets
34.46% 40.63% 40.09% 42.04%
Debt/Equity
1.98 18.95 2.76 5.44
Asset Turnover
0.67 0.72 0.70 0.79
Operating CF/Net income
0.51 0.30 0.57 0.16
Capex/Depreciation
(0.06) (0.02) (0.03) (0.06)
Interest Coverage
(3.52) (6.24) (4.92) (5.17)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
56.15% 61.87% 67.22% 100.61%
Intangible Assets out of Total Assets
0.43 0.50 0.46 0.48
Share Based Compensation of Revenue
0.00% 3.25% 0.00% 0.00%
Graham Net Nets
(2.67) (1.87) (1.55) (0.62)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(224.49%) (156.12%) (166.13%) (68.68%)
Free Cash Flow Yield
(96.70%) (105.76%) (102.57%) (43.91%)
Revenue per Share
0.71 0.71 0.66 0.60
Operating CF per Share
(0.21) (0.15) (0.25) (0.12)
Capex per Share
(0.01) 0.00 0.00 (0.01)
Free Cash Flow per Share
(0.22) (0.15) (0.25) (0.13)
Cash per Share
0.48 0.03 0.31 0.09
Shareholders Equity per Share
0.68 0.07 0.54 0.28
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.68 0.07 0.54 0.28
Free Cash Flow
(1.33) (0.91) (1.39) (0.71)
Working Capital
(5.89) (8.72) (4.57) (6.18)
Capital Expenditures
(0.04) (0.01) (0.02) (0.03)
Net Current Asset Value
(15.96) (19.03) (14.76) (16.61)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.00 0.01 0.01
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
0.07 0.11 0.25 0.13
Average Payables
1.89 2.80 2.65 2.59
Average Inventory
0.53 0.53 0.51 0.54
Average Assets
23.18 21.37 22.03 20.99
Average Common Equity
3.60 (1.33) 1.64 0.39

Fold the line items

Columns are period end dates